- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
Results
6
Companies which are potentially undervalued and in an acceptable financial position.
6 companies
Dong-A Socio Holdings
Market Cap: ₩547.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩81,800.00
7D
-5.3%
1Y
-28.6%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩245,500.00
7D
-2.4%
1Y
-34.8%
Dong-A ST
Market Cap: ₩348.4b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩36,350.00
7D
-4.1%
1Y
-22.2%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩120,800.00
7D
-4.5%
1Y
-25.7%
PharmaResearch
Market Cap: ₩2.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩288,500.00
7D
-2.7%
1Y
-44.8%
ST PharmLtd
Market Cap: ₩2.5t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩123,200.00
7D
-0.2%
1Y
48.4%